<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>Vascular Smooth Muscle Cells on Maragkakis Lab</title><link>http://maragkakislab.com/tags/vascular-smooth-muscle-cells/</link><description>Recent content in Vascular Smooth Muscle Cells on Maragkakis Lab</description><generator>Hugo</generator><language>en-us</language><lastBuildDate>Thu, 13 Nov 2025 00:00:00 +0000</lastBuildDate><atom:link href="http://maragkakislab.com/tags/vascular-smooth-muscle-cells/index.xml" rel="self" type="application/rss+xml"/><item><title>Senescence: An overlooked VSMC phenotype and therapeutic opportunity?</title><link>http://maragkakislab.com/publications/2025-senescence-vsmc/</link><pubDate>Thu, 13 Nov 2025 00:00:00 +0000</pubDate><guid>http://maragkakislab.com/publications/2025-senescence-vsmc/</guid><description>&lt;h2 id="summary"&gt;Summary&lt;/h2&gt;
&lt;p&gt;This review examines the evidence for senescence in vascular smooth muscle cells (VSMCs) and its contribution to vascular aging and disease. The authors discuss the mechanisms driving VSMC senescence, its downstream consequences for vascular function, and the potential for senolytic and senomorphic interventions.&lt;/p&gt;</description></item></channel></rss>